WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM

June 26, 2024

Company announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients

Company anticipates revenue of over $1.0 million in Q2, and over $3.5 million for 2024 on existing programs

Read more at prnewswire.com

Related news for (CANSF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.